Saburo Yagishita
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Saburo Yagishita has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Nobutaka Arai
Tokyo Med & Dent Univ TMDU, Grad Sch Med & Dent Sci, Dept Forens Med, 1-5-45 Yushima,Bunkyo Ku, Tokyo 1138519, Japan
2 shared publications - Akira Tamaoka
Department of Neurology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, 1-1-1, Tennoudai, Tsukuba, Ibaraki 305-8575, Japan
1 shared publication - Jun-Ichi Satoh
Department of Bioinformatics and Molecular Neuropathology, Meiji Pharmaceutical University, Tokyo, Japan
1 shared publication Kazuaki Misugi
Department of Pathology, Yokohama City University School of Medicine, Yokohama Japan
1 shared publication- Kenji Jinnai
Department of Neurology, NHO Hyogo-Chuo Hospital, Hyogo, Japan
1 shared publication Kiyoshi Iwabuchi
Department of Pathology, Kanagawa Rehabilitation Center, Atsugi-shi Japan
1 shared publication
Latest Publications
- Open Access
- 1 January 2014
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 9 (1) , 68
LC3, an autophagosome marker, is expressed on oligodendrocytes in Nasu-Hakola disease brains
Nasu-Hakola disease (NHD) is a rare autosomal recessive disorder characterized by sclerosing leukoencephalopathy and multifocal bone cysts, caused by a loss-of-function mutation of either DAP12 or TREM2. TREM2 and DAP12 constitute a receptor/adaptor signaling complex expressed exclusively on osteoclasts, dendritic cells, macrophages, and microglia. Neuropathologically, NHD exhibits profound loss of myelin and accumulation of axonal spheroids, accompanied by intense gliosis accentuated in the white matter of the frontal and temporal lobes. At present, the molecular mechanism responsible for development of leukoencephalopathy in NHD brains remains totally unknown.
- 1 January 2014
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 9 (1) , 68
Open AccessLC3, an autophagosome marker, is expressed on oligodendrocytes in Nasu-Hakola disease brains
Nasu-Hakola disease (NHD) is a rare autosomal recessive disorder characterized by sclerosing leukoencephalopathy and multifocal bone cysts, caused by a loss-of-function mutation of either DAP12 or TREM2. TREM2 and DAP12 constitute a receptor/adaptor signaling complex expressed exclusively on osteoclasts, dendritic cells, macrophages, and microglia. Neuropathologically, NHD exhibits profound loss of myelin and accumulation of axonal spheroids, accompanied by intense gliosis accentuated in the white matter of the frontal and temporal lobes. At present, the molecular mechanism responsible for development of leukoencephalopathy in NHD brains remains totally unknown.
- 31 December 1989
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 94 (1-3) , 319-323
“Grumose degeneration” of Trétiakoff
- 31 December 1989
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 94 (1-3) , 319-323
“Grumose degeneration” of Trétiakoff